Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Submitted by
admin
on January 24, 2011 - 8:22pm
Source:
Bloomberg
News Tags:
BioVex
Amgen
M&A
Oncovex
Headline:
Amgen to Buy Cancer Drugmaker Biovex for $425 Million
Do Not Allow Advertisers to Use My Personal information
